| scholarly article | Q13442814 |
| P2093 | author name string | Babita Shashni | |
| Karun Sharma | |||
| Kishore R Sakharkar | |||
| Meena K Sakharkar | |||
| Sarinder K Dhillon | |||
| Prabhakar R Ranjekar | |||
| P2860 | cites work | Antioxidant enzyme activities and oxidative stress in human breast cancer. | Q53475326 |
| Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes. | Q53558619 | ||
| Amelioration of age-related inflammation and oxidative stress by PPARgamma activator: suppression of NF-kappaB by 2,4-thiazolidinedione. | Q53596663 | ||
| Modulation of PPAR in aging, inflammation, and calorie restriction. | Q53631561 | ||
| Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer. | Q54039560 | ||
| Mitochondrial lipid peroxides and antioxidant enzymes in colorectal adenocarcinoma tissues. | Q55399026 | ||
| Energy balance, insulin resistance biomarkers, and breast cancer risk. | Q55474697 | ||
| Diabetes and Cancer: A Consensus Report | Q62267706 | ||
| The peroxisome proliferator activated receptor regulates malic enzyme gene expression | Q72724750 | ||
| NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4 | Q73256626 | ||
| Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies | Q81238531 | ||
| mTOR upregulation of glycolytic enzymes promotes tumor development | Q83586027 | ||
| Is there a role for carbohydrate restriction in the treatment and prevention of cancer? | Q21245058 | ||
| Cancer as a metabolic disease | Q21245061 | ||
| Pathway analysis of kidney cancer using proteomics and metabolic profiling | Q21245737 | ||
| PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer | Q21328702 | ||
| Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma | Q24311702 | ||
| Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria | Q24595940 | ||
| The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases | Q24612698 | ||
| Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy | Q24646296 | ||
| Expression of Mn-Superoxide Dismutase Gene in Nontumorigenic and Tumorigenic Human Mammary Epithelial Cells | Q24805807 | ||
| Troglitazone acts on cellular pH and DNA synthesis through a peroxisome proliferator-activated receptor gamma-independent mechanism in breast cancer-derived cell lines | Q45122025 | ||
| Benzoyl 2-methyl indoles as selective PPARgamma modulators | Q45190005 | ||
| Manganese superoxide dismutase expression in human central nervous system tumors | Q46482151 | ||
| Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice | Q46887401 | ||
| Targeted disruption of the murine Nhe1 locus induces ataxia, growth retardation, and seizures. | Q52177965 | ||
| Oleate activates phosphatidylinositol 3-kinase and promotes proliferation and reduces apoptosis of MDA-MB-231 breast cancer cells, whereas palmitate has opposite effects. | Q53403542 | ||
| A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors | Q27860552 | ||
| Obesity is associated with macrophage accumulation in adipose tissue | Q27860976 | ||
| The coregulator exchange in transcriptional functions of nuclear receptors | Q28131759 | ||
| Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis | Q28262820 | ||
| Why do cancers have high aerobic glycolysis? | Q28290710 | ||
| Cancer cell metabolism: Warburg and beyond | Q28293198 | ||
| Peroxisome proliferator-activated receptors: nuclear control of metabolism | Q28374684 | ||
| Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase | Q28587071 | ||
| A human peroxisome-proliferator-activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs | Q28609826 | ||
| Energy and redox homeostasis in tumor cells | Q28728744 | ||
| Aerobic glycolysis: meeting the metabolic requirements of cell proliferation | Q29615178 | ||
| An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma) | Q29615693 | ||
| Metabolic reprogramming: a cancer hallmark even warburg did not anticipate | Q29617612 | ||
| A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation | Q29619212 | ||
| The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation | Q29620219 | ||
| Temporal linkage between the phenotypic and genomic responses to caloric restriction | Q29999615 | ||
| Computational identification and experimental validation of PPRE motifs in NHE1 and MnSOD genes of human | Q30951265 | ||
| Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells | Q31463666 | ||
| Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect | Q33188191 | ||
| Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways: mechanism of tumorigenesis. | Q33237312 | ||
| Peroxisome proliferator-activated receptor-gamma activates p53 gene promoter binding to the nuclear factor-kappaB sequence in human MCF7 breast cancer cells | Q33252788 | ||
| Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer | Q33790538 | ||
| Peroxisome proliferator-activated receptor-gamma 34C>G polymorphism and colorectal cancer risk: a meta-analysis | Q33830757 | ||
| Subcellular localization of hexokinases I and II directs the metabolic fate of glucose | Q33847153 | ||
| Thiazolidinediones | Q34346862 | ||
| SIRT1 is regulated by a PPAR{γ}-SIRT1 negative feedback loop associated with senescence | Q34367932 | ||
| An overview on biological mechanisms of PPARs. | Q34381038 | ||
| pHi, aerobic glycolysis and vascular endothelial growth factor in tumour growth. | Q34452447 | ||
| The changing face of the Na+/H+ exchanger, NHE1: structure, regulation, and cellular actions | Q34504091 | ||
| Detection of resistance to imatinib by metabolic profiling: clinical and drug development implications | Q34561387 | ||
| Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review | Q34568687 | ||
| The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma | Q35013613 | ||
| Peroxisome proliferator-activated receptors: lipid binding proteins controling gene expression | Q35024425 | ||
| Superoxide dismutase: an emerging target for cancer therapeutics | Q35050415 | ||
| Angiotensin II, PPAR-gamma and atherosclerosis | Q35650829 | ||
| ROS stress in cancer cells and therapeutic implications | Q35781703 | ||
| Research resource: Diagnostic and therapeutic potential of nuclear receptor expression in lung cancer | Q36113804 | ||
| Diabetes and breast cancer risk: a meta-analysis. | Q36385281 | ||
| Orphan nuclear receptors: therapeutic opportunities in skeletal muscle. | Q36529528 | ||
| Protection from oxidative stress by enhanced glycolysis; a possible mechanism of cellular immortalization. | Q36665016 | ||
| Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis? | Q36877059 | ||
| Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor gamma (PPARgamma) and PPARgammacoactivator-1 (PGC1). | Q36954673 | ||
| Environmental contaminants as risk factors for developing diabetes | Q37192476 | ||
| Adipose tissue dysfunction in obesity, diabetes, and vascular diseases | Q37262617 | ||
| Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer | Q37269372 | ||
| Cellular stress and RNA splicing | Q37390107 | ||
| Metabolism and cancer: an up-to-date review of a mutual connection. | Q37845369 | ||
| mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging | Q37952583 | ||
| Targeted agents to reverse resistance to endocrine therapy in metastatic breast cancer: where are we now and where are we going? | Q38001839 | ||
| Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro | Q38318681 | ||
| Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). | Q38326047 | ||
| Glycolytic enzymes PGK1 and PKM2 as novel transcriptional targets of PPARγ in breast cancer pathophysiology | Q38494271 | ||
| Ion transport, membrane potential, and cytoplasmic pH in lymphocytes: changes during activation | Q38611850 | ||
| PPARγ disease gene network and identification of therapeutic targets for prostate cancer | Q39502492 | ||
| Anticancer activity of thymoquinone in breast cancer cells: possible involvement of PPAR-γ pathway. | Q39523385 | ||
| HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer | Q39763266 | ||
| Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand | Q39983038 | ||
| Acid-mediated tumor invasion: a multidisciplinary study | Q40278705 | ||
| Reactive oxygen species-mediated regulation of the Na+-H+ exchanger 1 gene expression connects intracellular redox status with cells' sensitivity to death triggers | Q40369823 | ||
| Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells | Q40565118 | ||
| Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells. | Q40734573 | ||
| Na+/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. | Q40845948 | ||
| Regulation of the formation of tumor cell pseudopodia by the Na(+)/H(+) exchanger NHE1. | Q40851358 | ||
| Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy | Q40889273 | ||
| An acidic environment leads to p53 dependent induction of apoptosis in human adenoma and carcinoma cell lines: implications for clonal selection during colorectal carcinogenesis. | Q40950295 | ||
| New roles for pyruvate kinase M2: working out the Warburg effect | Q41494903 | ||
| Oxidative stress: animal adaptations in nature. | Q41530836 | ||
| Pyruvate is a lipid precursor for rat lymphocytes in culture: evidence for a lipid exporting capacity | Q41543232 | ||
| Control of Glycolytic Flux by AMP-Activated Protein Kinase in Tumor Cells Adapted to Low pH | Q42127666 | ||
| Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice | Q42553759 | ||
| Type 2 diabetes mellitus and characteristics of breast cancer in China | Q42785576 | ||
| Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation. | Q42825125 | ||
| Interfering with ROS Metabolism in Cancer Cells: The Potential Role of Quercetin. | Q42875767 | ||
| Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells | Q43006369 | ||
| Growth inhibition and differentiation of pancreatic cancer cell lines by PPAR gamma ligand troglitazone | Q43820996 | ||
| Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. | Q44272057 | ||
| Saturated fatty acid-induced apoptosis in MDA-MB-231 breast cancer cells. A role for cardiolipin | Q44477318 | ||
| Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: a phase II study | Q44503536 | ||
| Enhancement of BRCA1 gene expression by the peroxisome proliferator-activated receptor gamma in the MCF-7 breast cancer cell line | Q44559508 | ||
| Elevated serum manganese superoxide dismutase in acute leukemias | Q44940277 | ||
| Oxidative stress and antioxidants in patients with cardiogenic shock complicating acute myocardial infarction | Q45060597 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 109285 | |
| P577 | publication date | 2013-02-03 | |
| P1433 | published in | PPAR Research | Q15756406 |
| P1476 | title | Therapeutic implications of targeting energy metabolism in breast cancer | |
| P478 | volume | 2013 |
| Q35101709 | Coffee component hydroxyl hydroquinone (HHQ) as a putative ligand for PPAR gamma and implications in breast cancer |
| Q35748982 | Differential Utilization of Dietary Fatty Acids in Benign and Malignant Cells of the Prostate |
| Q38970906 | Inhibition of HDAC increases the senescence induced by natural polyphenols in glioma cells |
| Q34042201 | Rosiglitazone accentuates the adipogenesis of hemangioma-derived mesenchymal stem cells induced by adipogenic media |
| Q38868671 | Upregulated PFTK1 promotes tumor cell proliferation, migration, and invasion in breast cancer |
Search more.